CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market buy Director bought 142,045 shares at $7.04 ($999,997)
- 4 Open-market buy Director bought 18,373 shares at an average $6.06 ($111,425)
- 4 Open-market buy Director bought 3,488,372 shares at $0.43 ($1,500,000)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 988 shares at $0.42 ($411)
- 4 Open-market sale President & CEO sold 3,772 shares at $0.42 ($1,570)
- 4 Open-market sale Chief Commercial Officer sold 476 shares at $0.42 ($198)
- 4 Open-market sale Chief Development Officer sold 442 shares at $0.42 ($184)
- 4 Open-market sale Chief Accounting Officer sold 228 shares at $0.42 ($95)
- 4 Exercise or conversion Director acquired 22,874 shares (option exercise)
- 4 Exercise or conversion Director acquired 26,368 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,723,239 shares at an average $0.28 ($1,316,624)
- 4 Open-market sale Chief Accounting Officer sold 224 shares at an average $0.36 ($80)
- 4 Open-market sale Chief Development Officer sold 445 shares at an average $0.36 ($158)
- 4 Open-market sale Chief Commercial Officer sold 477 shares at an average $0.36 ($170)
Page 3 of 17 · 336 filings